National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 60881 [2018-25788]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
Room 7351, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8886,
sanoviche@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25792 Filed 11–26–18; 8:45 am]
BILLING CODE 4140–01–P
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Amir Emanuel Zeituni,
Ph.D., Scientific Review Program, DEA/
NIAID/NIH/DHHS, 5601 Fishers Lane, MSC–
9834, Rockville, MD 20852, 301–496–2550.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25788 Filed 11–26–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
amozie on DSK3GDR082PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Immune Mechanisms of
Protection Against Mycobacterium
Tuberculosis Center (IMPAC–TB).
Date: December 6–7, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, DEA/SRP, Rm. 3G53A,
National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Rockville, MD
20892–9823, 301–761–7322, julio.aliberti@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; ‘‘Acquired
Immunodeficiency Syndrome Research
Review Committee (AIDS) Special Emphasis
Panel’’.
Date: December 19, 2018.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:45 Nov 26, 2018
Jkt 247001
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Alcohol Abuse and
Alcoholism.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The intramural programs
and projects as well as the grant
applications and/or contract proposals
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with intramural
programs and projects as well as the
grant applications and/or contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Date: February 7, 2019.
Closed: 9:00 a.m. to 9:20 a.m.
Agenda: Presentation of the AABSC
Report.
Place: National Institutes of Health,
Rockledge 6700, 6700 B Rockledge Drive,
Conference Rooms A, B & C, Bethesda, MD
20817.
Closed: 9:20 a.m. to 10:00 a.m.
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
60881
Agenda: To review and evaluate grant
applications and/or contract proposals.
Place: National Institutes of Health,
Rockledge 6700, 6700 B Rockledge Drive,
Conference Rooms A, B & C, Bethesda, MD
20817.
Open: 10:00 a.m. to 3:00 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
Rockledge 6700, 6700 B Rockledge Drive,
Conference Rooms A, B & C, Bethesda, MD
20817.
Contact Person: Abraham P. Bautista,
Ph.D., Executive Secretary, National
Advisory Council, National Institute on
Alcohol Abuse & Alcoholism, National
Institutes of Health, 6700 B Rockledge Drive,
Suite 1458, MSC 6902, Rockville, MD 20852,
301–443–9737, bautista@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/AboutNIAAA/
AdvisoryCouncil/Pages/default.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: November 20, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25785 Filed 11–26–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request Data and Specimen
Hub (DASH) (Eunice Kennedy Shriver
National Institute of Child Health and
Human Development); Correction
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice; correction.
The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on November 7, 2018.
That Notice inadvertently contained an
error in the SUPPLEMENTARY INFORMATION
section.
SUMMARY:
E:\FR\FM\27NON1.SGM
27NON1
]]>Agencies
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Page 60881]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25788]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Immune Mechanisms of Protection
Against Mycobacterium Tuberculosis Center (IMPAC-TB).
Date: December 6-7, 2018.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Julio C. Aliberti, Ph.D., Scientific Review
Officer, Immunology Review Branch, DEA/SRP, Rm. 3G53A, National
Institutes of Health, NIAID, 5601 Fishers Lane, MSC 9823, Rockville,
MD 20892-9823, 301-761-7322, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; ``Acquired Immunodeficiency
Syndrome Research Review Committee (AIDS) Special Emphasis Panel''.
Date: December 19, 2018.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Amir Emanuel Zeituni, Ph.D., Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, MSC-9834, Rockville,
MD 20852, 301-496-2550.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 20, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-25788 Filed 11-26-18; 8:45 am]
BILLING CODE 4140-01-P
